Autonomics Flashcards
Ibuprofen: Brand name
Motrin; related naproxen (Aleve)
Ibuprofen: Drug Class (6)
Pharmacologic–NSAID
Therapeutic–analgesic, antipyretic, anti-inflammatory, anti-gout, anti-dysmennorhea
Ibuprofen: Pharmacodynamics
Exact mechanism unclear, but most likely involves inhibition of prostaglandin synthesis via COX 1 and COX 2 (effects on pain, inflammation, kidney, stomach)
Ibuprofen: Pharmacokinetics (4)
F=80%
Extensive metabolism in liver
Some is excreted unchanged in urine
Half-life about 2-4 h
Ibuprofen: Toxicity issues (contraindications, precautions, warnings, ADRs, etc) (3)
Avoid in patients “allergic” to aspirin (asthma, nasal polyps, etc)
Use with caution in patients with renal compromise or ulcer disease
Fluid retention in CHF patients
Ibuprofen: Drug interactions (4)
Warfarin
Aspirin
Diuretics
Antihypertensives
Ibuprofen: Special considerations
Greater potential for toxicity in geriatric patients
Ibuprofen: Dose/route (not necessary to know)
OTC 200-400 mg po q4h prn pain; higher doses by prescription only
Norepinephrine: Brand name (2)
Noradrenaline, Levophed
Norepinephrine: Drug class (3)
Pharmacologic class—direct-acting adrenergic agonist
Therapeutic class —vasopressor, vasoconstrictor
Norepinephrine: Pharmacodynamics (4)
Major action is to stimulate peripheral alpha-1 adrenoceptors –> vasoconstriction (resistance arterioles, increase SVR) and venoconstriction (in capacitance vessels, increase preload)
- -> Increases CO, SVR, and MAP
- -> Decreases blood flow to vulnerable tissues like skin, muscle, and kidney
- -> Stimulates beta-1 receptors in the heart, increasing HR and contractility; main effects are vasoconstriction and cardiac stimulation.
Norepinephrine: Pharmacokinetics (6)
F ~100%
Given IV only
Metabolized by COMT and MAO, mostly in liver
Metabolites are excreted in urine
Half-life 1-2 minutes (e.g. can be titrated quickly IV)
Can cross the placenta, but not the blood/brain barrier.
Norepinephrine: Toxicity issues (contraindications, precautions, warnings, ADRs, etc) (2)
Excessive vasoconstriction in mesenteric vessels, peripheral arterioles causing ischemia, infarction, gangrene
Reflex bradycardia
Norepinephrine: Drug interactions (2)
Use cautiously in patients taking an MAO inhibitor such as phenelzine (use lower doses)
Risk of excessive hypertension in patients taking propranolol
Norepinephrine: Special considerations (4)
Correct volume depletion with IV fluids BEFORE giving NE infusion
Select infusion site carefully—extravasation is a major problem
Monitor patient and BP continuously in ICU setting
Use cautiously in pediatric and geriatric patients